News

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.
The blood thinner Eliquis was Bristol Myers Squibb’s highest revenue-generating medication last year. It was also one of the 10 drugs that were subject to Medicare price negotiations under the ...
Apixaban, a new anticoagulant, appears to offer an efficacy and safety profile comparable with that of enoxaparin for preventing VTE after orthopedic surgery, with the advantage of oral ...